Global Drug Excipients
Global Drug Excipients

Drug Excipients Comprehensive Study by Type (Organic Chemicals, Inorganic Chemicals, Others), Application (Solid Drugs, Semisolid Drugs, Liquid Drugs), Functionality (Disintegrants, Colorants, Lubricants and Glidants, Preservatives, Emulsifying Agents, Other Functionalities, Others), Formulation (Oral, Topical, Parenteral, Other) Players and Region - Global Market Outlook to 2025

Drug Excipients Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Oct 2020 Edition 226 Pages 165 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Drug Excipients?
Drug excipients assume a significant part in the assembling of drugs by assisting with protecting the viability, security, and usefulness of the APIs. Excipients are dormant substances defined alongside the dynamic drug ingredient(s) (APIs) of medicine for building up of details or to give a helpful improvement of API in the last dose form. Currently, Regulatory organizations are getting progressively worried about the quality and security of excipients and are instituting new guidelines requiring drug producers to guarantee the nature of their fixings. Moreover, the Growth of the Pharmaceuticals Market Backed By Functional Excipients is one of the key driving factors of growth

The market study is broken down by Type (Organic Chemicals, Inorganic Chemicals and Others), by Application (Solid Drugs, Semisolid Drugs and Liquid Drugs) and major geographies with country level break-up.

The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that Players from United States will contribute to the maximum growth of Global Drug Excipients market throughout the predicted period.

Associated British Foods (United Kingdom), Archer Daniels Midland Company (United States), Lubrizol Corporation (United States), and Croda International (United Kingdom), Innophous Holdings (United States), Ashland Global Holdings (United States), BASF SE (Germany), DuPont (United States), Roquette Feres (France) and Evonik Industries AG (Germany) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Kerry Group (Ireland), WACKER Chemie AG (Germany), Colorcon (United States), DFE Pharma (Germany), JRS Pharma (Germany) and Air Liquide (France).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Drug Excipients market by Type, Application and Region.

On the basis of geography, the market of Drug Excipients has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Functionality, the sub-segment i.e. Disintegrants will boost the Drug Excipients market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Formulation, the sub-segment i.e. Oral will boost the Drug Excipients market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Leaders and their expansionary development strategies
In August 2020 Germany based company Evonik Industries AG announced their acquisition with the Porocel for USD 210 million to accelerate the growth of the catalysts business.

"Under U.S. law, an excipient, unlike an active drug substance, has no regulatory status and may not be sold for use in food or approved drugs unless it can be qualified through one or more of the three U.S. Food and Drug Administration (FDA) approval mechanisms", “FDA that the substance is "generally recognized as safe" (GRAS) pursuant to Title 21, U.S. Code of Federal Regulations, Parts 182, 184 or 186 (21 CFR 182, 184 & 186)”, “Under U.S. law, an excipient, unlike an active drug substance, has no regulatory status and may not be sold for use in food or approved drugs unless it can be qualified through one or more of the three U.S. Food and Drug Administration (FDA) approval mechanisms that are available for components used in the food and/or finished new drug dosage forms.” and “International Pharmaceutical Excipients Council. It regulates and frames the standards such as quality, safety, and functionality for pharmaceutical excipients”

Market Drivers
  • Growing Uptake of Biopharmaceuticals
  • Increasing Adoption of Orphan Drugs

Opportunities
  • Shifting Inclination of Pharmaceutical Manufacturing to Emerging Countries

Restraints
  • Stringent Government Regulations

Challenges
  • Changing Trade Policies Between Countries


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Drug Excipients Manufacturer, Drug Excipients Suppliers, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry

About Approach
During this study the evaluation and validation of the market size is done through various sources including primary and secondary analysis. AMA Research & Media follows industrial and regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Organic Chemicals
  • Inorganic Chemicals
  • Others
By Application
  • Solid Drugs
  • Semisolid Drugs
  • Liquid Drugs
By Functionality
  • Disintegrants
  • Colorants
  • Lubricants and Glidants
  • Preservatives
  • Emulsifying Agents
  • Other Functionalities
  • Others

By Formulation
  • Oral
  • Topical
  • Parenteral
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Uptake of Biopharmaceuticals
      • 3.2.2. Increasing Adoption of Orphan Drugs
    • 3.3. Market Challenges
      • 3.3.1. Changing Trade Policies Between Countries
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Drug Excipients, by Type, Application, Functionality, Formulation and Region (value, volume and price ) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Drug Excipients (Value)
      • 5.2.1. Global Drug Excipients by: Type (Value)
        • 5.2.1.1. Organic Chemicals
        • 5.2.1.2. Inorganic Chemicals
        • 5.2.1.3. Others
      • 5.2.2. Global Drug Excipients by: Application (Value)
        • 5.2.2.1. Solid Drugs
        • 5.2.2.2. Semisolid Drugs
        • 5.2.2.3. Liquid Drugs
      • 5.2.3. Global Drug Excipients by: Functionality (Value)
        • 5.2.3.1. Disintegrants
        • 5.2.3.2. Colorants
        • 5.2.3.3. Lubricants and Glidants
        • 5.2.3.4. Preservatives
        • 5.2.3.5. Emulsifying Agents
        • 5.2.3.6. Other Functionalities
        • 5.2.3.7. Others
      • 5.2.4. Global Drug Excipients by: Formulation (Value)
        • 5.2.4.1. Oral
        • 5.2.4.2. Topical
        • 5.2.4.3. Parenteral
        • 5.2.4.4. Other
      • 5.2.5. Global Drug Excipients Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Drug Excipients (Volume)
      • 5.3.1. Global Drug Excipients by: Type (Volume)
        • 5.3.1.1. Organic Chemicals
        • 5.3.1.2. Inorganic Chemicals
        • 5.3.1.3. Others
      • 5.3.2. Global Drug Excipients by: Application (Volume)
        • 5.3.2.1. Solid Drugs
        • 5.3.2.2. Semisolid Drugs
        • 5.3.2.3. Liquid Drugs
      • 5.3.3. Global Drug Excipients by: Functionality (Volume)
        • 5.3.3.1. Disintegrants
        • 5.3.3.2. Colorants
        • 5.3.3.3. Lubricants and Glidants
        • 5.3.3.4. Preservatives
        • 5.3.3.5. Emulsifying Agents
        • 5.3.3.6. Other Functionalities
        • 5.3.3.7. Others
      • 5.3.4. Global Drug Excipients by: Formulation (Volume)
        • 5.3.4.1. Oral
        • 5.3.4.2. Topical
        • 5.3.4.3. Parenteral
        • 5.3.4.4. Other
      • 5.3.5. Global Drug Excipients Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Drug Excipients (Price)
      • 5.4.1. Global Drug Excipients by: Type (Price)
  • 6. Drug Excipients: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Associated British Foods (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Archer Daniels Midland Company (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Lubrizol Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. And Croda International (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Innophous Holdings (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Ashland Global Holdings (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. BASF SE (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. DuPont (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Roquette Feres (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Evonik Industries AG (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Drug Excipients Sale, by Type, Application, Functionality, Formulation and Region (value, volume and price ) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Drug Excipients (Value)
      • 7.2.1. Global Drug Excipients by: Type (Value)
        • 7.2.1.1. Organic Chemicals
        • 7.2.1.2. Inorganic Chemicals
        • 7.2.1.3. Others
      • 7.2.2. Global Drug Excipients by: Application (Value)
        • 7.2.2.1. Solid Drugs
        • 7.2.2.2. Semisolid Drugs
        • 7.2.2.3. Liquid Drugs
      • 7.2.3. Global Drug Excipients by: Functionality (Value)
        • 7.2.3.1. Disintegrants
        • 7.2.3.2. Colorants
        • 7.2.3.3. Lubricants and Glidants
        • 7.2.3.4. Preservatives
        • 7.2.3.5. Emulsifying Agents
        • 7.2.3.6. Other Functionalities
        • 7.2.3.7. Others
      • 7.2.4. Global Drug Excipients by: Formulation (Value)
        • 7.2.4.1. Oral
        • 7.2.4.2. Topical
        • 7.2.4.3. Parenteral
        • 7.2.4.4. Other
      • 7.2.5. Global Drug Excipients Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Drug Excipients (Volume)
      • 7.3.1. Global Drug Excipients by: Type (Volume)
        • 7.3.1.1. Organic Chemicals
        • 7.3.1.2. Inorganic Chemicals
        • 7.3.1.3. Others
      • 7.3.2. Global Drug Excipients by: Application (Volume)
        • 7.3.2.1. Solid Drugs
        • 7.3.2.2. Semisolid Drugs
        • 7.3.2.3. Liquid Drugs
      • 7.3.3. Global Drug Excipients by: Functionality (Volume)
        • 7.3.3.1. Disintegrants
        • 7.3.3.2. Colorants
        • 7.3.3.3. Lubricants and Glidants
        • 7.3.3.4. Preservatives
        • 7.3.3.5. Emulsifying Agents
        • 7.3.3.6. Other Functionalities
        • 7.3.3.7. Others
      • 7.3.4. Global Drug Excipients by: Formulation (Volume)
        • 7.3.4.1. Oral
        • 7.3.4.2. Topical
        • 7.3.4.3. Parenteral
        • 7.3.4.4. Other
      • 7.3.5. Global Drug Excipients Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Drug Excipients (Price)
      • 7.4.1. Global Drug Excipients by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Drug Excipients: by Type(USD Million)
  • Table 2. Drug Excipients Organic Chemicals , by Region USD Million (2014-2019)
  • Table 3. Drug Excipients Inorganic Chemicals , by Region USD Million (2014-2019)
  • Table 4. Drug Excipients Others , by Region USD Million (2014-2019)
  • Table 5. Drug Excipients: by Application(USD Million)
  • Table 6. Drug Excipients Solid Drugs , by Region USD Million (2014-2019)
  • Table 7. Drug Excipients Semisolid Drugs , by Region USD Million (2014-2019)
  • Table 8. Drug Excipients Liquid Drugs , by Region USD Million (2014-2019)
  • Table 9. Drug Excipients: by Functionality(USD Million)
  • Table 10. Drug Excipients Disintegrants , by Region USD Million (2014-2019)
  • Table 11. Drug Excipients Colorants , by Region USD Million (2014-2019)
  • Table 12. Drug Excipients Lubricants and Glidants , by Region USD Million (2014-2019)
  • Table 13. Drug Excipients Preservatives , by Region USD Million (2014-2019)
  • Table 14. Drug Excipients Emulsifying Agents , by Region USD Million (2014-2019)
  • Table 15. Drug Excipients Other Functionalities , by Region USD Million (2014-2019)
  • Table 16. Drug Excipients Others , by Region USD Million (2014-2019)
  • Table 17. Drug Excipients: by Formulation(USD Million)
  • Table 18. Drug Excipients Oral , by Region USD Million (2014-2019)
  • Table 19. Drug Excipients Topical , by Region USD Million (2014-2019)
  • Table 20. Drug Excipients Parenteral , by Region USD Million (2014-2019)
  • Table 21. Drug Excipients Other , by Region USD Million (2014-2019)
  • Table 22. South America Drug Excipients, by Country USD Million (2014-2019)
  • Table 23. South America Drug Excipients, by Type USD Million (2014-2019)
  • Table 24. South America Drug Excipients, by Application USD Million (2014-2019)
  • Table 25. South America Drug Excipients, by Functionality USD Million (2014-2019)
  • Table 26. South America Drug Excipients, by Formulation USD Million (2014-2019)
  • Table 27. Brazil Drug Excipients, by Type USD Million (2014-2019)
  • Table 28. Brazil Drug Excipients, by Application USD Million (2014-2019)
  • Table 29. Brazil Drug Excipients, by Functionality USD Million (2014-2019)
  • Table 30. Brazil Drug Excipients, by Formulation USD Million (2014-2019)
  • Table 31. Argentina Drug Excipients, by Type USD Million (2014-2019)
  • Table 32. Argentina Drug Excipients, by Application USD Million (2014-2019)
  • Table 33. Argentina Drug Excipients, by Functionality USD Million (2014-2019)
  • Table 34. Argentina Drug Excipients, by Formulation USD Million (2014-2019)
  • Table 35. Rest of South America Drug Excipients, by Type USD Million (2014-2019)
  • Table 36. Rest of South America Drug Excipients, by Application USD Million (2014-2019)
  • Table 37. Rest of South America Drug Excipients, by Functionality USD Million (2014-2019)
  • Table 38. Rest of South America Drug Excipients, by Formulation USD Million (2014-2019)
  • Table 39. Asia Pacific Drug Excipients, by Country USD Million (2014-2019)
  • Table 40. Asia Pacific Drug Excipients, by Type USD Million (2014-2019)
  • Table 41. Asia Pacific Drug Excipients, by Application USD Million (2014-2019)
  • Table 42. Asia Pacific Drug Excipients, by Functionality USD Million (2014-2019)
  • Table 43. Asia Pacific Drug Excipients, by Formulation USD Million (2014-2019)
  • Table 44. China Drug Excipients, by Type USD Million (2014-2019)
  • Table 45. China Drug Excipients, by Application USD Million (2014-2019)
  • Table 46. China Drug Excipients, by Functionality USD Million (2014-2019)
  • Table 47. China Drug Excipients, by Formulation USD Million (2014-2019)
  • Table 48. Japan Drug Excipients, by Type USD Million (2014-2019)
  • Table 49. Japan Drug Excipients, by Application USD Million (2014-2019)
  • Table 50. Japan Drug Excipients, by Functionality USD Million (2014-2019)
  • Table 51. Japan Drug Excipients, by Formulation USD Million (2014-2019)
  • Table 52. India Drug Excipients, by Type USD Million (2014-2019)
  • Table 53. India Drug Excipients, by Application USD Million (2014-2019)
  • Table 54. India Drug Excipients, by Functionality USD Million (2014-2019)
  • Table 55. India Drug Excipients, by Formulation USD Million (2014-2019)
  • Table 56. South Korea Drug Excipients, by Type USD Million (2014-2019)
  • Table 57. South Korea Drug Excipients, by Application USD Million (2014-2019)
  • Table 58. South Korea Drug Excipients, by Functionality USD Million (2014-2019)
  • Table 59. South Korea Drug Excipients, by Formulation USD Million (2014-2019)
  • Table 60. Taiwan Drug Excipients, by Type USD Million (2014-2019)
  • Table 61. Taiwan Drug Excipients, by Application USD Million (2014-2019)
  • Table 62. Taiwan Drug Excipients, by Functionality USD Million (2014-2019)
  • Table 63. Taiwan Drug Excipients, by Formulation USD Million (2014-2019)
  • Table 64. Australia Drug Excipients, by Type USD Million (2014-2019)
  • Table 65. Australia Drug Excipients, by Application USD Million (2014-2019)
  • Table 66. Australia Drug Excipients, by Functionality USD Million (2014-2019)
  • Table 67. Australia Drug Excipients, by Formulation USD Million (2014-2019)
  • Table 68. Rest of Asia-Pacific Drug Excipients, by Type USD Million (2014-2019)
  • Table 69. Rest of Asia-Pacific Drug Excipients, by Application USD Million (2014-2019)
  • Table 70. Rest of Asia-Pacific Drug Excipients, by Functionality USD Million (2014-2019)
  • Table 71. Rest of Asia-Pacific Drug Excipients, by Formulation USD Million (2014-2019)
  • Table 72. Europe Drug Excipients, by Country USD Million (2014-2019)
  • Table 73. Europe Drug Excipients, by Type USD Million (2014-2019)
  • Table 74. Europe Drug Excipients, by Application USD Million (2014-2019)
  • Table 75. Europe Drug Excipients, by Functionality USD Million (2014-2019)
  • Table 76. Europe Drug Excipients, by Formulation USD Million (2014-2019)
  • Table 77. Germany Drug Excipients, by Type USD Million (2014-2019)
  • Table 78. Germany Drug Excipients, by Application USD Million (2014-2019)
  • Table 79. Germany Drug Excipients, by Functionality USD Million (2014-2019)
  • Table 80. Germany Drug Excipients, by Formulation USD Million (2014-2019)
  • Table 81. France Drug Excipients, by Type USD Million (2014-2019)
  • Table 82. France Drug Excipients, by Application USD Million (2014-2019)
  • Table 83. France Drug Excipients, by Functionality USD Million (2014-2019)
  • Table 84. France Drug Excipients, by Formulation USD Million (2014-2019)
  • Table 85. Italy Drug Excipients, by Type USD Million (2014-2019)
  • Table 86. Italy Drug Excipients, by Application USD Million (2014-2019)
  • Table 87. Italy Drug Excipients, by Functionality USD Million (2014-2019)
  • Table 88. Italy Drug Excipients, by Formulation USD Million (2014-2019)
  • Table 89. United Kingdom Drug Excipients, by Type USD Million (2014-2019)
  • Table 90. United Kingdom Drug Excipients, by Application USD Million (2014-2019)
  • Table 91. United Kingdom Drug Excipients, by Functionality USD Million (2014-2019)
  • Table 92. United Kingdom Drug Excipients, by Formulation USD Million (2014-2019)
  • Table 93. Netherlands Drug Excipients, by Type USD Million (2014-2019)
  • Table 94. Netherlands Drug Excipients, by Application USD Million (2014-2019)
  • Table 95. Netherlands Drug Excipients, by Functionality USD Million (2014-2019)
  • Table 96. Netherlands Drug Excipients, by Formulation USD Million (2014-2019)
  • Table 97. Rest of Europe Drug Excipients, by Type USD Million (2014-2019)
  • Table 98. Rest of Europe Drug Excipients, by Application USD Million (2014-2019)
  • Table 99. Rest of Europe Drug Excipients, by Functionality USD Million (2014-2019)
  • Table 100. Rest of Europe Drug Excipients, by Formulation USD Million (2014-2019)
  • Table 101. MEA Drug Excipients, by Country USD Million (2014-2019)
  • Table 102. MEA Drug Excipients, by Type USD Million (2014-2019)
  • Table 103. MEA Drug Excipients, by Application USD Million (2014-2019)
  • Table 104. MEA Drug Excipients, by Functionality USD Million (2014-2019)
  • Table 105. MEA Drug Excipients, by Formulation USD Million (2014-2019)
  • Table 106. Middle East Drug Excipients, by Type USD Million (2014-2019)
  • Table 107. Middle East Drug Excipients, by Application USD Million (2014-2019)
  • Table 108. Middle East Drug Excipients, by Functionality USD Million (2014-2019)
  • Table 109. Middle East Drug Excipients, by Formulation USD Million (2014-2019)
  • Table 110. Africa Drug Excipients, by Type USD Million (2014-2019)
  • Table 111. Africa Drug Excipients, by Application USD Million (2014-2019)
  • Table 112. Africa Drug Excipients, by Functionality USD Million (2014-2019)
  • Table 113. Africa Drug Excipients, by Formulation USD Million (2014-2019)
  • Table 114. North America Drug Excipients, by Country USD Million (2014-2019)
  • Table 115. North America Drug Excipients, by Type USD Million (2014-2019)
  • Table 116. North America Drug Excipients, by Application USD Million (2014-2019)
  • Table 117. North America Drug Excipients, by Functionality USD Million (2014-2019)
  • Table 118. North America Drug Excipients, by Formulation USD Million (2014-2019)
  • Table 119. United States Drug Excipients, by Type USD Million (2014-2019)
  • Table 120. United States Drug Excipients, by Application USD Million (2014-2019)
  • Table 121. United States Drug Excipients, by Functionality USD Million (2014-2019)
  • Table 122. United States Drug Excipients, by Formulation USD Million (2014-2019)
  • Table 123. Canada Drug Excipients, by Type USD Million (2014-2019)
  • Table 124. Canada Drug Excipients, by Application USD Million (2014-2019)
  • Table 125. Canada Drug Excipients, by Functionality USD Million (2014-2019)
  • Table 126. Canada Drug Excipients, by Formulation USD Million (2014-2019)
  • Table 127. Mexico Drug Excipients, by Type USD Million (2014-2019)
  • Table 128. Mexico Drug Excipients, by Application USD Million (2014-2019)
  • Table 129. Mexico Drug Excipients, by Functionality USD Million (2014-2019)
  • Table 130. Mexico Drug Excipients, by Formulation USD Million (2014-2019)
  • Table 131. Drug Excipients Sales: by Type(K Units)
  • Table 132. Drug Excipients Sales Organic Chemicals , by Region K Units (2014-2019)
  • Table 133. Drug Excipients Sales Inorganic Chemicals , by Region K Units (2014-2019)
  • Table 134. Drug Excipients Sales Others , by Region K Units (2014-2019)
  • Table 135. Drug Excipients Sales: by Application(K Units)
  • Table 136. Drug Excipients Sales Solid Drugs , by Region K Units (2014-2019)
  • Table 137. Drug Excipients Sales Semisolid Drugs , by Region K Units (2014-2019)
  • Table 138. Drug Excipients Sales Liquid Drugs , by Region K Units (2014-2019)
  • Table 139. Drug Excipients Sales: by Functionality(K Units)
  • Table 140. Drug Excipients Sales Disintegrants , by Region K Units (2014-2019)
  • Table 141. Drug Excipients Sales Colorants , by Region K Units (2014-2019)
  • Table 142. Drug Excipients Sales Lubricants and Glidants , by Region K Units (2014-2019)
  • Table 143. Drug Excipients Sales Preservatives , by Region K Units (2014-2019)
  • Table 144. Drug Excipients Sales Emulsifying Agents , by Region K Units (2014-2019)
  • Table 145. Drug Excipients Sales Other Functionalities , by Region K Units (2014-2019)
  • Table 146. Drug Excipients Sales Others , by Region K Units (2014-2019)
  • Table 147. Drug Excipients Sales: by Formulation(K Units)
  • Table 148. Drug Excipients Sales Oral , by Region K Units (2014-2019)
  • Table 149. Drug Excipients Sales Topical , by Region K Units (2014-2019)
  • Table 150. Drug Excipients Sales Parenteral , by Region K Units (2014-2019)
  • Table 151. Drug Excipients Sales Other , by Region K Units (2014-2019)
  • Table 152. South America Drug Excipients Sales, by Country K Units (2014-2019)
  • Table 153. South America Drug Excipients Sales, by Type K Units (2014-2019)
  • Table 154. South America Drug Excipients Sales, by Application K Units (2014-2019)
  • Table 155. South America Drug Excipients Sales, by Functionality K Units (2014-2019)
  • Table 156. South America Drug Excipients Sales, by Formulation K Units (2014-2019)
  • Table 157. Brazil Drug Excipients Sales, by Type K Units (2014-2019)
  • Table 158. Brazil Drug Excipients Sales, by Application K Units (2014-2019)
  • Table 159. Brazil Drug Excipients Sales, by Functionality K Units (2014-2019)
  • Table 160. Brazil Drug Excipients Sales, by Formulation K Units (2014-2019)
  • Table 161. Argentina Drug Excipients Sales, by Type K Units (2014-2019)
  • Table 162. Argentina Drug Excipients Sales, by Application K Units (2014-2019)
  • Table 163. Argentina Drug Excipients Sales, by Functionality K Units (2014-2019)
  • Table 164. Argentina Drug Excipients Sales, by Formulation K Units (2014-2019)
  • Table 165. Rest of South America Drug Excipients Sales, by Type K Units (2014-2019)
  • Table 166. Rest of South America Drug Excipients Sales, by Application K Units (2014-2019)
  • Table 167. Rest of South America Drug Excipients Sales, by Functionality K Units (2014-2019)
  • Table 168. Rest of South America Drug Excipients Sales, by Formulation K Units (2014-2019)
  • Table 169. Asia Pacific Drug Excipients Sales, by Country K Units (2014-2019)
  • Table 170. Asia Pacific Drug Excipients Sales, by Type K Units (2014-2019)
  • Table 171. Asia Pacific Drug Excipients Sales, by Application K Units (2014-2019)
  • Table 172. Asia Pacific Drug Excipients Sales, by Functionality K Units (2014-2019)
  • Table 173. Asia Pacific Drug Excipients Sales, by Formulation K Units (2014-2019)
  • Table 174. China Drug Excipients Sales, by Type K Units (2014-2019)
  • Table 175. China Drug Excipients Sales, by Application K Units (2014-2019)
  • Table 176. China Drug Excipients Sales, by Functionality K Units (2014-2019)
  • Table 177. China Drug Excipients Sales, by Formulation K Units (2014-2019)
  • Table 178. Japan Drug Excipients Sales, by Type K Units (2014-2019)
  • Table 179. Japan Drug Excipients Sales, by Application K Units (2014-2019)
  • Table 180. Japan Drug Excipients Sales, by Functionality K Units (2014-2019)
  • Table 181. Japan Drug Excipients Sales, by Formulation K Units (2014-2019)
  • Table 182. India Drug Excipients Sales, by Type K Units (2014-2019)
  • Table 183. India Drug Excipients Sales, by Application K Units (2014-2019)
  • Table 184. India Drug Excipients Sales, by Functionality K Units (2014-2019)
  • Table 185. India Drug Excipients Sales, by Formulation K Units (2014-2019)
  • Table 186. South Korea Drug Excipients Sales, by Type K Units (2014-2019)
  • Table 187. South Korea Drug Excipients Sales, by Application K Units (2014-2019)
  • Table 188. South Korea Drug Excipients Sales, by Functionality K Units (2014-2019)
  • Table 189. South Korea Drug Excipients Sales, by Formulation K Units (2014-2019)
  • Table 190. Taiwan Drug Excipients Sales, by Type K Units (2014-2019)
  • Table 191. Taiwan Drug Excipients Sales, by Application K Units (2014-2019)
  • Table 192. Taiwan Drug Excipients Sales, by Functionality K Units (2014-2019)
  • Table 193. Taiwan Drug Excipients Sales, by Formulation K Units (2014-2019)
  • Table 194. Australia Drug Excipients Sales, by Type K Units (2014-2019)
  • Table 195. Australia Drug Excipients Sales, by Application K Units (2014-2019)
  • Table 196. Australia Drug Excipients Sales, by Functionality K Units (2014-2019)
  • Table 197. Australia Drug Excipients Sales, by Formulation K Units (2014-2019)
  • Table 198. Rest of Asia-Pacific Drug Excipients Sales, by Type K Units (2014-2019)
  • Table 199. Rest of Asia-Pacific Drug Excipients Sales, by Application K Units (2014-2019)
  • Table 200. Rest of Asia-Pacific Drug Excipients Sales, by Functionality K Units (2014-2019)
  • Table 201. Rest of Asia-Pacific Drug Excipients Sales, by Formulation K Units (2014-2019)
  • Table 202. Europe Drug Excipients Sales, by Country K Units (2014-2019)
  • Table 203. Europe Drug Excipients Sales, by Type K Units (2014-2019)
  • Table 204. Europe Drug Excipients Sales, by Application K Units (2014-2019)
  • Table 205. Europe Drug Excipients Sales, by Functionality K Units (2014-2019)
  • Table 206. Europe Drug Excipients Sales, by Formulation K Units (2014-2019)
  • Table 207. Germany Drug Excipients Sales, by Type K Units (2014-2019)
  • Table 208. Germany Drug Excipients Sales, by Application K Units (2014-2019)
  • Table 209. Germany Drug Excipients Sales, by Functionality K Units (2014-2019)
  • Table 210. Germany Drug Excipients Sales, by Formulation K Units (2014-2019)
  • Table 211. France Drug Excipients Sales, by Type K Units (2014-2019)
  • Table 212. France Drug Excipients Sales, by Application K Units (2014-2019)
  • Table 213. France Drug Excipients Sales, by Functionality K Units (2014-2019)
  • Table 214. France Drug Excipients Sales, by Formulation K Units (2014-2019)
  • Table 215. Italy Drug Excipients Sales, by Type K Units (2014-2019)
  • Table 216. Italy Drug Excipients Sales, by Application K Units (2014-2019)
  • Table 217. Italy Drug Excipients Sales, by Functionality K Units (2014-2019)
  • Table 218. Italy Drug Excipients Sales, by Formulation K Units (2014-2019)
  • Table 219. United Kingdom Drug Excipients Sales, by Type K Units (2014-2019)
  • Table 220. United Kingdom Drug Excipients Sales, by Application K Units (2014-2019)
  • Table 221. United Kingdom Drug Excipients Sales, by Functionality K Units (2014-2019)
  • Table 222. United Kingdom Drug Excipients Sales, by Formulation K Units (2014-2019)
  • Table 223. Netherlands Drug Excipients Sales, by Type K Units (2014-2019)
  • Table 224. Netherlands Drug Excipients Sales, by Application K Units (2014-2019)
  • Table 225. Netherlands Drug Excipients Sales, by Functionality K Units (2014-2019)
  • Table 226. Netherlands Drug Excipients Sales, by Formulation K Units (2014-2019)
  • Table 227. Rest of Europe Drug Excipients Sales, by Type K Units (2014-2019)
  • Table 228. Rest of Europe Drug Excipients Sales, by Application K Units (2014-2019)
  • Table 229. Rest of Europe Drug Excipients Sales, by Functionality K Units (2014-2019)
  • Table 230. Rest of Europe Drug Excipients Sales, by Formulation K Units (2014-2019)
  • Table 231. MEA Drug Excipients Sales, by Country K Units (2014-2019)
  • Table 232. MEA Drug Excipients Sales, by Type K Units (2014-2019)
  • Table 233. MEA Drug Excipients Sales, by Application K Units (2014-2019)
  • Table 234. MEA Drug Excipients Sales, by Functionality K Units (2014-2019)
  • Table 235. MEA Drug Excipients Sales, by Formulation K Units (2014-2019)
  • Table 236. Middle East Drug Excipients Sales, by Type K Units (2014-2019)
  • Table 237. Middle East Drug Excipients Sales, by Application K Units (2014-2019)
  • Table 238. Middle East Drug Excipients Sales, by Functionality K Units (2014-2019)
  • Table 239. Middle East Drug Excipients Sales, by Formulation K Units (2014-2019)
  • Table 240. Africa Drug Excipients Sales, by Type K Units (2014-2019)
  • Table 241. Africa Drug Excipients Sales, by Application K Units (2014-2019)
  • Table 242. Africa Drug Excipients Sales, by Functionality K Units (2014-2019)
  • Table 243. Africa Drug Excipients Sales, by Formulation K Units (2014-2019)
  • Table 244. North America Drug Excipients Sales, by Country K Units (2014-2019)
  • Table 245. North America Drug Excipients Sales, by Type K Units (2014-2019)
  • Table 246. North America Drug Excipients Sales, by Application K Units (2014-2019)
  • Table 247. North America Drug Excipients Sales, by Functionality K Units (2014-2019)
  • Table 248. North America Drug Excipients Sales, by Formulation K Units (2014-2019)
  • Table 249. United States Drug Excipients Sales, by Type K Units (2014-2019)
  • Table 250. United States Drug Excipients Sales, by Application K Units (2014-2019)
  • Table 251. United States Drug Excipients Sales, by Functionality K Units (2014-2019)
  • Table 252. United States Drug Excipients Sales, by Formulation K Units (2014-2019)
  • Table 253. Canada Drug Excipients Sales, by Type K Units (2014-2019)
  • Table 254. Canada Drug Excipients Sales, by Application K Units (2014-2019)
  • Table 255. Canada Drug Excipients Sales, by Functionality K Units (2014-2019)
  • Table 256. Canada Drug Excipients Sales, by Formulation K Units (2014-2019)
  • Table 257. Mexico Drug Excipients Sales, by Type K Units (2014-2019)
  • Table 258. Mexico Drug Excipients Sales, by Application K Units (2014-2019)
  • Table 259. Mexico Drug Excipients Sales, by Functionality K Units (2014-2019)
  • Table 260. Mexico Drug Excipients Sales, by Formulation K Units (2014-2019)
  • Table 261. Drug Excipients: by Type(USD/Units)
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Company Basic Information, Sales Area and Its Competitors
  • Table 265. Company Basic Information, Sales Area and Its Competitors
  • Table 266. Company Basic Information, Sales Area and Its Competitors
  • Table 267. Company Basic Information, Sales Area and Its Competitors
  • Table 268. Company Basic Information, Sales Area and Its Competitors
  • Table 269. Company Basic Information, Sales Area and Its Competitors
  • Table 270. Company Basic Information, Sales Area and Its Competitors
  • Table 271. Company Basic Information, Sales Area and Its Competitors
  • Table 272. Drug Excipients: by Type(USD Million)
  • Table 273. Drug Excipients Organic Chemicals , by Region USD Million (2020-2025)
  • Table 274. Drug Excipients Inorganic Chemicals , by Region USD Million (2020-2025)
  • Table 275. Drug Excipients Others , by Region USD Million (2020-2025)
  • Table 276. Drug Excipients: by Application(USD Million)
  • Table 277. Drug Excipients Solid Drugs , by Region USD Million (2020-2025)
  • Table 278. Drug Excipients Semisolid Drugs , by Region USD Million (2020-2025)
  • Table 279. Drug Excipients Liquid Drugs , by Region USD Million (2020-2025)
  • Table 280. Drug Excipients: by Functionality(USD Million)
  • Table 281. Drug Excipients Disintegrants , by Region USD Million (2020-2025)
  • Table 282. Drug Excipients Colorants , by Region USD Million (2020-2025)
  • Table 283. Drug Excipients Lubricants and Glidants , by Region USD Million (2020-2025)
  • Table 284. Drug Excipients Preservatives , by Region USD Million (2020-2025)
  • Table 285. Drug Excipients Emulsifying Agents , by Region USD Million (2020-2025)
  • Table 286. Drug Excipients Other Functionalities , by Region USD Million (2020-2025)
  • Table 287. Drug Excipients Others , by Region USD Million (2020-2025)
  • Table 288. Drug Excipients: by Formulation(USD Million)
  • Table 289. Drug Excipients Oral , by Region USD Million (2020-2025)
  • Table 290. Drug Excipients Topical , by Region USD Million (2020-2025)
  • Table 291. Drug Excipients Parenteral , by Region USD Million (2020-2025)
  • Table 292. Drug Excipients Other , by Region USD Million (2020-2025)
  • Table 293. South America Drug Excipients, by Country USD Million (2020-2025)
  • Table 294. South America Drug Excipients, by Type USD Million (2020-2025)
  • Table 295. South America Drug Excipients, by Application USD Million (2020-2025)
  • Table 296. South America Drug Excipients, by Functionality USD Million (2020-2025)
  • Table 297. South America Drug Excipients, by Formulation USD Million (2020-2025)
  • Table 298. Brazil Drug Excipients, by Type USD Million (2020-2025)
  • Table 299. Brazil Drug Excipients, by Application USD Million (2020-2025)
  • Table 300. Brazil Drug Excipients, by Functionality USD Million (2020-2025)
  • Table 301. Brazil Drug Excipients, by Formulation USD Million (2020-2025)
  • Table 302. Argentina Drug Excipients, by Type USD Million (2020-2025)
  • Table 303. Argentina Drug Excipients, by Application USD Million (2020-2025)
  • Table 304. Argentina Drug Excipients, by Functionality USD Million (2020-2025)
  • Table 305. Argentina Drug Excipients, by Formulation USD Million (2020-2025)
  • Table 306. Rest of South America Drug Excipients, by Type USD Million (2020-2025)
  • Table 307. Rest of South America Drug Excipients, by Application USD Million (2020-2025)
  • Table 308. Rest of South America Drug Excipients, by Functionality USD Million (2020-2025)
  • Table 309. Rest of South America Drug Excipients, by Formulation USD Million (2020-2025)
  • Table 310. Asia Pacific Drug Excipients, by Country USD Million (2020-2025)
  • Table 311. Asia Pacific Drug Excipients, by Type USD Million (2020-2025)
  • Table 312. Asia Pacific Drug Excipients, by Application USD Million (2020-2025)
  • Table 313. Asia Pacific Drug Excipients, by Functionality USD Million (2020-2025)
  • Table 314. Asia Pacific Drug Excipients, by Formulation USD Million (2020-2025)
  • Table 315. China Drug Excipients, by Type USD Million (2020-2025)
  • Table 316. China Drug Excipients, by Application USD Million (2020-2025)
  • Table 317. China Drug Excipients, by Functionality USD Million (2020-2025)
  • Table 318. China Drug Excipients, by Formulation USD Million (2020-2025)
  • Table 319. Japan Drug Excipients, by Type USD Million (2020-2025)
  • Table 320. Japan Drug Excipients, by Application USD Million (2020-2025)
  • Table 321. Japan Drug Excipients, by Functionality USD Million (2020-2025)
  • Table 322. Japan Drug Excipients, by Formulation USD Million (2020-2025)
  • Table 323. India Drug Excipients, by Type USD Million (2020-2025)
  • Table 324. India Drug Excipients, by Application USD Million (2020-2025)
  • Table 325. India Drug Excipients, by Functionality USD Million (2020-2025)
  • Table 326. India Drug Excipients, by Formulation USD Million (2020-2025)
  • Table 327. South Korea Drug Excipients, by Type USD Million (2020-2025)
  • Table 328. South Korea Drug Excipients, by Application USD Million (2020-2025)
  • Table 329. South Korea Drug Excipients, by Functionality USD Million (2020-2025)
  • Table 330. South Korea Drug Excipients, by Formulation USD Million (2020-2025)
  • Table 331. Taiwan Drug Excipients, by Type USD Million (2020-2025)
  • Table 332. Taiwan Drug Excipients, by Application USD Million (2020-2025)
  • Table 333. Taiwan Drug Excipients, by Functionality USD Million (2020-2025)
  • Table 334. Taiwan Drug Excipients, by Formulation USD Million (2020-2025)
  • Table 335. Australia Drug Excipients, by Type USD Million (2020-2025)
  • Table 336. Australia Drug Excipients, by Application USD Million (2020-2025)
  • Table 337. Australia Drug Excipients, by Functionality USD Million (2020-2025)
  • Table 338. Australia Drug Excipients, by Formulation USD Million (2020-2025)
  • Table 339. Rest of Asia-Pacific Drug Excipients, by Type USD Million (2020-2025)
  • Table 340. Rest of Asia-Pacific Drug Excipients, by Application USD Million (2020-2025)
  • Table 341. Rest of Asia-Pacific Drug Excipients, by Functionality USD Million (2020-2025)
  • Table 342. Rest of Asia-Pacific Drug Excipients, by Formulation USD Million (2020-2025)
  • Table 343. Europe Drug Excipients, by Country USD Million (2020-2025)
  • Table 344. Europe Drug Excipients, by Type USD Million (2020-2025)
  • Table 345. Europe Drug Excipients, by Application USD Million (2020-2025)
  • Table 346. Europe Drug Excipients, by Functionality USD Million (2020-2025)
  • Table 347. Europe Drug Excipients, by Formulation USD Million (2020-2025)
  • Table 348. Germany Drug Excipients, by Type USD Million (2020-2025)
  • Table 349. Germany Drug Excipients, by Application USD Million (2020-2025)
  • Table 350. Germany Drug Excipients, by Functionality USD Million (2020-2025)
  • Table 351. Germany Drug Excipients, by Formulation USD Million (2020-2025)
  • Table 352. France Drug Excipients, by Type USD Million (2020-2025)
  • Table 353. France Drug Excipients, by Application USD Million (2020-2025)
  • Table 354. France Drug Excipients, by Functionality USD Million (2020-2025)
  • Table 355. France Drug Excipients, by Formulation USD Million (2020-2025)
  • Table 356. Italy Drug Excipients, by Type USD Million (2020-2025)
  • Table 357. Italy Drug Excipients, by Application USD Million (2020-2025)
  • Table 358. Italy Drug Excipients, by Functionality USD Million (2020-2025)
  • Table 359. Italy Drug Excipients, by Formulation USD Million (2020-2025)
  • Table 360. United Kingdom Drug Excipients, by Type USD Million (2020-2025)
  • Table 361. United Kingdom Drug Excipients, by Application USD Million (2020-2025)
  • Table 362. United Kingdom Drug Excipients, by Functionality USD Million (2020-2025)
  • Table 363. United Kingdom Drug Excipients, by Formulation USD Million (2020-2025)
  • Table 364. Netherlands Drug Excipients, by Type USD Million (2020-2025)
  • Table 365. Netherlands Drug Excipients, by Application USD Million (2020-2025)
  • Table 366. Netherlands Drug Excipients, by Functionality USD Million (2020-2025)
  • Table 367. Netherlands Drug Excipients, by Formulation USD Million (2020-2025)
  • Table 368. Rest of Europe Drug Excipients, by Type USD Million (2020-2025)
  • Table 369. Rest of Europe Drug Excipients, by Application USD Million (2020-2025)
  • Table 370. Rest of Europe Drug Excipients, by Functionality USD Million (2020-2025)
  • Table 371. Rest of Europe Drug Excipients, by Formulation USD Million (2020-2025)
  • Table 372. MEA Drug Excipients, by Country USD Million (2020-2025)
  • Table 373. MEA Drug Excipients, by Type USD Million (2020-2025)
  • Table 374. MEA Drug Excipients, by Application USD Million (2020-2025)
  • Table 375. MEA Drug Excipients, by Functionality USD Million (2020-2025)
  • Table 376. MEA Drug Excipients, by Formulation USD Million (2020-2025)
  • Table 377. Middle East Drug Excipients, by Type USD Million (2020-2025)
  • Table 378. Middle East Drug Excipients, by Application USD Million (2020-2025)
  • Table 379. Middle East Drug Excipients, by Functionality USD Million (2020-2025)
  • Table 380. Middle East Drug Excipients, by Formulation USD Million (2020-2025)
  • Table 381. Africa Drug Excipients, by Type USD Million (2020-2025)
  • Table 382. Africa Drug Excipients, by Application USD Million (2020-2025)
  • Table 383. Africa Drug Excipients, by Functionality USD Million (2020-2025)
  • Table 384. Africa Drug Excipients, by Formulation USD Million (2020-2025)
  • Table 385. North America Drug Excipients, by Country USD Million (2020-2025)
  • Table 386. North America Drug Excipients, by Type USD Million (2020-2025)
  • Table 387. North America Drug Excipients, by Application USD Million (2020-2025)
  • Table 388. North America Drug Excipients, by Functionality USD Million (2020-2025)
  • Table 389. North America Drug Excipients, by Formulation USD Million (2020-2025)
  • Table 390. United States Drug Excipients, by Type USD Million (2020-2025)
  • Table 391. United States Drug Excipients, by Application USD Million (2020-2025)
  • Table 392. United States Drug Excipients, by Functionality USD Million (2020-2025)
  • Table 393. United States Drug Excipients, by Formulation USD Million (2020-2025)
  • Table 394. Canada Drug Excipients, by Type USD Million (2020-2025)
  • Table 395. Canada Drug Excipients, by Application USD Million (2020-2025)
  • Table 396. Canada Drug Excipients, by Functionality USD Million (2020-2025)
  • Table 397. Canada Drug Excipients, by Formulation USD Million (2020-2025)
  • Table 398. Mexico Drug Excipients, by Type USD Million (2020-2025)
  • Table 399. Mexico Drug Excipients, by Application USD Million (2020-2025)
  • Table 400. Mexico Drug Excipients, by Functionality USD Million (2020-2025)
  • Table 401. Mexico Drug Excipients, by Formulation USD Million (2020-2025)
  • Table 402. Drug Excipients Sales: by Type(K Units)
  • Table 403. Drug Excipients Sales Organic Chemicals , by Region K Units (2020-2025)
  • Table 404. Drug Excipients Sales Inorganic Chemicals , by Region K Units (2020-2025)
  • Table 405. Drug Excipients Sales Others , by Region K Units (2020-2025)
  • Table 406. Drug Excipients Sales: by Application(K Units)
  • Table 407. Drug Excipients Sales Solid Drugs , by Region K Units (2020-2025)
  • Table 408. Drug Excipients Sales Semisolid Drugs , by Region K Units (2020-2025)
  • Table 409. Drug Excipients Sales Liquid Drugs , by Region K Units (2020-2025)
  • Table 410. Drug Excipients Sales: by Functionality(K Units)
  • Table 411. Drug Excipients Sales Disintegrants , by Region K Units (2020-2025)
  • Table 412. Drug Excipients Sales Colorants , by Region K Units (2020-2025)
  • Table 413. Drug Excipients Sales Lubricants and Glidants , by Region K Units (2020-2025)
  • Table 414. Drug Excipients Sales Preservatives , by Region K Units (2020-2025)
  • Table 415. Drug Excipients Sales Emulsifying Agents , by Region K Units (2020-2025)
  • Table 416. Drug Excipients Sales Other Functionalities , by Region K Units (2020-2025)
  • Table 417. Drug Excipients Sales Others , by Region K Units (2020-2025)
  • Table 418. Drug Excipients Sales: by Formulation(K Units)
  • Table 419. Drug Excipients Sales Oral , by Region K Units (2020-2025)
  • Table 420. Drug Excipients Sales Topical , by Region K Units (2020-2025)
  • Table 421. Drug Excipients Sales Parenteral , by Region K Units (2020-2025)
  • Table 422. Drug Excipients Sales Other , by Region K Units (2020-2025)
  • Table 423. South America Drug Excipients Sales, by Country K Units (2020-2025)
  • Table 424. South America Drug Excipients Sales, by Type K Units (2020-2025)
  • Table 425. South America Drug Excipients Sales, by Application K Units (2020-2025)
  • Table 426. South America Drug Excipients Sales, by Functionality K Units (2020-2025)
  • Table 427. South America Drug Excipients Sales, by Formulation K Units (2020-2025)
  • Table 428. Brazil Drug Excipients Sales, by Type K Units (2020-2025)
  • Table 429. Brazil Drug Excipients Sales, by Application K Units (2020-2025)
  • Table 430. Brazil Drug Excipients Sales, by Functionality K Units (2020-2025)
  • Table 431. Brazil Drug Excipients Sales, by Formulation K Units (2020-2025)
  • Table 432. Argentina Drug Excipients Sales, by Type K Units (2020-2025)
  • Table 433. Argentina Drug Excipients Sales, by Application K Units (2020-2025)
  • Table 434. Argentina Drug Excipients Sales, by Functionality K Units (2020-2025)
  • Table 435. Argentina Drug Excipients Sales, by Formulation K Units (2020-2025)
  • Table 436. Rest of South America Drug Excipients Sales, by Type K Units (2020-2025)
  • Table 437. Rest of South America Drug Excipients Sales, by Application K Units (2020-2025)
  • Table 438. Rest of South America Drug Excipients Sales, by Functionality K Units (2020-2025)
  • Table 439. Rest of South America Drug Excipients Sales, by Formulation K Units (2020-2025)
  • Table 440. Asia Pacific Drug Excipients Sales, by Country K Units (2020-2025)
  • Table 441. Asia Pacific Drug Excipients Sales, by Type K Units (2020-2025)
  • Table 442. Asia Pacific Drug Excipients Sales, by Application K Units (2020-2025)
  • Table 443. Asia Pacific Drug Excipients Sales, by Functionality K Units (2020-2025)
  • Table 444. Asia Pacific Drug Excipients Sales, by Formulation K Units (2020-2025)
  • Table 445. China Drug Excipients Sales, by Type K Units (2020-2025)
  • Table 446. China Drug Excipients Sales, by Application K Units (2020-2025)
  • Table 447. China Drug Excipients Sales, by Functionality K Units (2020-2025)
  • Table 448. China Drug Excipients Sales, by Formulation K Units (2020-2025)
  • Table 449. Japan Drug Excipients Sales, by Type K Units (2020-2025)
  • Table 450. Japan Drug Excipients Sales, by Application K Units (2020-2025)
  • Table 451. Japan Drug Excipients Sales, by Functionality K Units (2020-2025)
  • Table 452. Japan Drug Excipients Sales, by Formulation K Units (2020-2025)
  • Table 453. India Drug Excipients Sales, by Type K Units (2020-2025)
  • Table 454. India Drug Excipients Sales, by Application K Units (2020-2025)
  • Table 455. India Drug Excipients Sales, by Functionality K Units (2020-2025)
  • Table 456. India Drug Excipients Sales, by Formulation K Units (2020-2025)
  • Table 457. South Korea Drug Excipients Sales, by Type K Units (2020-2025)
  • Table 458. South Korea Drug Excipients Sales, by Application K Units (2020-2025)
  • Table 459. South Korea Drug Excipients Sales, by Functionality K Units (2020-2025)
  • Table 460. South Korea Drug Excipients Sales, by Formulation K Units (2020-2025)
  • Table 461. Taiwan Drug Excipients Sales, by Type K Units (2020-2025)
  • Table 462. Taiwan Drug Excipients Sales, by Application K Units (2020-2025)
  • Table 463. Taiwan Drug Excipients Sales, by Functionality K Units (2020-2025)
  • Table 464. Taiwan Drug Excipients Sales, by Formulation K Units (2020-2025)
  • Table 465. Australia Drug Excipients Sales, by Type K Units (2020-2025)
  • Table 466. Australia Drug Excipients Sales, by Application K Units (2020-2025)
  • Table 467. Australia Drug Excipients Sales, by Functionality K Units (2020-2025)
  • Table 468. Australia Drug Excipients Sales, by Formulation K Units (2020-2025)
  • Table 469. Rest of Asia-Pacific Drug Excipients Sales, by Type K Units (2020-2025)
  • Table 470. Rest of Asia-Pacific Drug Excipients Sales, by Application K Units (2020-2025)
  • Table 471. Rest of Asia-Pacific Drug Excipients Sales, by Functionality K Units (2020-2025)
  • Table 472. Rest of Asia-Pacific Drug Excipients Sales, by Formulation K Units (2020-2025)
  • Table 473. Europe Drug Excipients Sales, by Country K Units (2020-2025)
  • Table 474. Europe Drug Excipients Sales, by Type K Units (2020-2025)
  • Table 475. Europe Drug Excipients Sales, by Application K Units (2020-2025)
  • Table 476. Europe Drug Excipients Sales, by Functionality K Units (2020-2025)
  • Table 477. Europe Drug Excipients Sales, by Formulation K Units (2020-2025)
  • Table 478. Germany Drug Excipients Sales, by Type K Units (2020-2025)
  • Table 479. Germany Drug Excipients Sales, by Application K Units (2020-2025)
  • Table 480. Germany Drug Excipients Sales, by Functionality K Units (2020-2025)
  • Table 481. Germany Drug Excipients Sales, by Formulation K Units (2020-2025)
  • Table 482. France Drug Excipients Sales, by Type K Units (2020-2025)
  • Table 483. France Drug Excipients Sales, by Application K Units (2020-2025)
  • Table 484. France Drug Excipients Sales, by Functionality K Units (2020-2025)
  • Table 485. France Drug Excipients Sales, by Formulation K Units (2020-2025)
  • Table 486. Italy Drug Excipients Sales, by Type K Units (2020-2025)
  • Table 487. Italy Drug Excipients Sales, by Application K Units (2020-2025)
  • Table 488. Italy Drug Excipients Sales, by Functionality K Units (2020-2025)
  • Table 489. Italy Drug Excipients Sales, by Formulation K Units (2020-2025)
  • Table 490. United Kingdom Drug Excipients Sales, by Type K Units (2020-2025)
  • Table 491. United Kingdom Drug Excipients Sales, by Application K Units (2020-2025)
  • Table 492. United Kingdom Drug Excipients Sales, by Functionality K Units (2020-2025)
  • Table 493. United Kingdom Drug Excipients Sales, by Formulation K Units (2020-2025)
  • Table 494. Netherlands Drug Excipients Sales, by Type K Units (2020-2025)
  • Table 495. Netherlands Drug Excipients Sales, by Application K Units (2020-2025)
  • Table 496. Netherlands Drug Excipients Sales, by Functionality K Units (2020-2025)
  • Table 497. Netherlands Drug Excipients Sales, by Formulation K Units (2020-2025)
  • Table 498. Rest of Europe Drug Excipients Sales, by Type K Units (2020-2025)
  • Table 499. Rest of Europe Drug Excipients Sales, by Application K Units (2020-2025)
  • Table 500. Rest of Europe Drug Excipients Sales, by Functionality K Units (2020-2025)
  • Table 501. Rest of Europe Drug Excipients Sales, by Formulation K Units (2020-2025)
  • Table 502. MEA Drug Excipients Sales, by Country K Units (2020-2025)
  • Table 503. MEA Drug Excipients Sales, by Type K Units (2020-2025)
  • Table 504. MEA Drug Excipients Sales, by Application K Units (2020-2025)
  • Table 505. MEA Drug Excipients Sales, by Functionality K Units (2020-2025)
  • Table 506. MEA Drug Excipients Sales, by Formulation K Units (2020-2025)
  • Table 507. Middle East Drug Excipients Sales, by Type K Units (2020-2025)
  • Table 508. Middle East Drug Excipients Sales, by Application K Units (2020-2025)
  • Table 509. Middle East Drug Excipients Sales, by Functionality K Units (2020-2025)
  • Table 510. Middle East Drug Excipients Sales, by Formulation K Units (2020-2025)
  • Table 511. Africa Drug Excipients Sales, by Type K Units (2020-2025)
  • Table 512. Africa Drug Excipients Sales, by Application K Units (2020-2025)
  • Table 513. Africa Drug Excipients Sales, by Functionality K Units (2020-2025)
  • Table 514. Africa Drug Excipients Sales, by Formulation K Units (2020-2025)
  • Table 515. North America Drug Excipients Sales, by Country K Units (2020-2025)
  • Table 516. North America Drug Excipients Sales, by Type K Units (2020-2025)
  • Table 517. North America Drug Excipients Sales, by Application K Units (2020-2025)
  • Table 518. North America Drug Excipients Sales, by Functionality K Units (2020-2025)
  • Table 519. North America Drug Excipients Sales, by Formulation K Units (2020-2025)
  • Table 520. United States Drug Excipients Sales, by Type K Units (2020-2025)
  • Table 521. United States Drug Excipients Sales, by Application K Units (2020-2025)
  • Table 522. United States Drug Excipients Sales, by Functionality K Units (2020-2025)
  • Table 523. United States Drug Excipients Sales, by Formulation K Units (2020-2025)
  • Table 524. Canada Drug Excipients Sales, by Type K Units (2020-2025)
  • Table 525. Canada Drug Excipients Sales, by Application K Units (2020-2025)
  • Table 526. Canada Drug Excipients Sales, by Functionality K Units (2020-2025)
  • Table 527. Canada Drug Excipients Sales, by Formulation K Units (2020-2025)
  • Table 528. Mexico Drug Excipients Sales, by Type K Units (2020-2025)
  • Table 529. Mexico Drug Excipients Sales, by Application K Units (2020-2025)
  • Table 530. Mexico Drug Excipients Sales, by Functionality K Units (2020-2025)
  • Table 531. Mexico Drug Excipients Sales, by Formulation K Units (2020-2025)
  • Table 532. Drug Excipients: by Type(USD/Units)
  • Table 533. Research Programs/Design for This Report
  • Table 534. Key Data Information from Secondary Sources
  • Table 535. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Drug Excipients: by Type USD Million (2014-2019)
  • Figure 5. Global Drug Excipients: by Application USD Million (2014-2019)
  • Figure 6. Global Drug Excipients: by Functionality USD Million (2014-2019)
  • Figure 7. Global Drug Excipients: by Formulation USD Million (2014-2019)
  • Figure 8. South America Drug Excipients Share (%), by Country
  • Figure 9. Asia Pacific Drug Excipients Share (%), by Country
  • Figure 10. Europe Drug Excipients Share (%), by Country
  • Figure 11. MEA Drug Excipients Share (%), by Country
  • Figure 12. North America Drug Excipients Share (%), by Country
  • Figure 13. Global Drug Excipients: by Type K Units (2014-2019)
  • Figure 14. Global Drug Excipients: by Application K Units (2014-2019)
  • Figure 15. Global Drug Excipients: by Functionality K Units (2014-2019)
  • Figure 16. Global Drug Excipients: by Formulation K Units (2014-2019)
  • Figure 17. South America Drug Excipients Share (%), by Country
  • Figure 18. Asia Pacific Drug Excipients Share (%), by Country
  • Figure 19. Europe Drug Excipients Share (%), by Country
  • Figure 20. MEA Drug Excipients Share (%), by Country
  • Figure 21. North America Drug Excipients Share (%), by Country
  • Figure 22. Global Drug Excipients: by Type USD/Units (2014-2019)
  • Figure 23. Global Drug Excipients share by Players 2019 (%)
  • Figure 24. Global Drug Excipients share by Players (Top 3) 2019(%)
  • Figure 25. Global Drug Excipients share by Players (Top 5) 2019(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Associated British Foods (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. Associated British Foods (United Kingdom) Revenue: by Geography 2019
  • Figure 29. Archer Daniels Midland Company (United States) Revenue, Net Income and Gross profit
  • Figure 30. Archer Daniels Midland Company (United States) Revenue: by Geography 2019
  • Figure 31. Lubrizol Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 32. Lubrizol Corporation (United States) Revenue: by Geography 2019
  • Figure 33. And Croda International (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. And Croda International (United Kingdom) Revenue: by Geography 2019
  • Figure 35. Innophous Holdings (United States) Revenue, Net Income and Gross profit
  • Figure 36. Innophous Holdings (United States) Revenue: by Geography 2019
  • Figure 37. Ashland Global Holdings (United States) Revenue, Net Income and Gross profit
  • Figure 38. Ashland Global Holdings (United States) Revenue: by Geography 2019
  • Figure 39. BASF SE (Germany) Revenue, Net Income and Gross profit
  • Figure 40. BASF SE (Germany) Revenue: by Geography 2019
  • Figure 41. DuPont (United States) Revenue, Net Income and Gross profit
  • Figure 42. DuPont (United States) Revenue: by Geography 2019
  • Figure 43. Roquette Feres (France) Revenue, Net Income and Gross profit
  • Figure 44. Roquette Feres (France) Revenue: by Geography 2019
  • Figure 45. Evonik Industries AG (Germany) Revenue, Net Income and Gross profit
  • Figure 46. Evonik Industries AG (Germany) Revenue: by Geography 2019
  • Figure 47. Global Drug Excipients: by Type USD Million (2020-2025)
  • Figure 48. Global Drug Excipients: by Application USD Million (2020-2025)
  • Figure 49. Global Drug Excipients: by Functionality USD Million (2020-2025)
  • Figure 50. Global Drug Excipients: by Formulation USD Million (2020-2025)
  • Figure 51. South America Drug Excipients Share (%), by Country
  • Figure 52. Asia Pacific Drug Excipients Share (%), by Country
  • Figure 53. Europe Drug Excipients Share (%), by Country
  • Figure 54. MEA Drug Excipients Share (%), by Country
  • Figure 55. North America Drug Excipients Share (%), by Country
  • Figure 56. Global Drug Excipients: by Type K Units (2020-2025)
  • Figure 57. Global Drug Excipients: by Application K Units (2020-2025)
  • Figure 58. Global Drug Excipients: by Functionality K Units (2020-2025)
  • Figure 59. Global Drug Excipients: by Formulation K Units (2020-2025)
  • Figure 60. South America Drug Excipients Share (%), by Country
  • Figure 61. Asia Pacific Drug Excipients Share (%), by Country
  • Figure 62. Europe Drug Excipients Share (%), by Country
  • Figure 63. MEA Drug Excipients Share (%), by Country
  • Figure 64. North America Drug Excipients Share (%), by Country
  • Figure 65. Global Drug Excipients: by Type USD/Units (2020-2025)
Some of the key companies/manufacturers profiled in the report
  • Associated British Foods (United Kingdom)
  • Archer Daniels Midland Company (United States)
  • Lubrizol Corporation (United States)
  • and Croda International (United Kingdom)
  • Innophous Holdings (United States)
  • Ashland Global Holdings (United States)
  • BASF SE (Germany)
  • DuPont (United States)
  • Roquette Feres (France)
  • Evonik Industries AG (Germany)
Additional players considered in the study are as follows:
Kerry Group (Ireland) , WACKER Chemie AG (Germany) , Colorcon (United States) , DFE Pharma (Germany) , JRS Pharma (Germany) , Air Liquide (France)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation